Clinical trial
FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC
NCT06403111
Study timeline
Study start (actual)2024-06-01Date precision: day
Registry last updated2024-12-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancerunresolved
Interventions
Fecal Microbiota Transplantation (FMT)+chemotherapy+immunotherapyCOMBINATION_PRODUCT
Sponsors & collaborators
Changzhou No.2 People's Hospitallead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06403111 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.